SEC Company Response from Korro Bio, (KRRO) — Mar 18, 2026
Korro Bio, Inc.
Date: March 18, 2026 · CIK: 0001703647 · Accession: 0001193125-26-114501
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294298
Letter
Re:
VIA EDGAR March 18, 2026 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Tim Buchmiller
Korro Bio, Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-294298
Acceleration Request
Requested Date:
March 20, 2026
Requested Time:
4:15 p.m., Eastern Time Dear Mr. Buchmiller: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), Korro Bio, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement (the “ Registration Statement ”) be accelerated to March 20, 2026, at 4:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134. If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134.
Sincerely,
KORRO BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR March 18, 2026 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Tim Buchmiller Re: Korro Bio, Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-294298 Acceleration Request Requested Date: March 20, 2026 Requested Time: 4:15 p.m., Eastern Time Dear Mr. Buchmiller: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), Korro Bio, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement (the “ Registration Statement ”) be accelerated to March 20, 2026, at 4:15 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134. If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134. Sincerely, KORRO BIO, INC. /s/ Ram Aiyar Ram Aiyar President, Chief Executive Officer and Interim Chief Financial Officer Korro Bio, Inc. cc: Jeffrey Cerio, General Counsel, Korro Bio, Inc. Kingsley L. Taft, Esq., Goodwin Procter LLP Marianne Sarrazin, Esq., Goodwin Procter LLP